Skip to main content
. Author manuscript; available in PMC: 2012 Sep 25.
Published in final edited form as: Toxicol Appl Pharmacol. 2010 Aug 20;249(1):47–54. doi: 10.1016/j.taap.2010.08.013

Table II.

Dermatological findings in the study populations

Clinical Outcome Unexposed
Group (N = 41)		 Exposed Group (N = 50)
Exposed with skin
lesion (N = 34)		 Exposed without
skin lesion (N = 16)
Raindrop Pigmentation
N (%)
Present 0 (0) 33 (97.06) 0 (0)
Absent 41 (100) 1 (2.94) 16 (100)
Hyperkeratosis
N (%)
Present 0 (0) 29 (85.29) 0 (0)
Absent 41 (100) 5 (14.71) 16 (100)
Hyperpigmentation
N (%)
Present 0 (0) 8 (23.53) 0 (0)
Absent 41 (100) 26 (76.47) 16 (100)
Bowen’s Disease
N (%)
Present 0 (0) 1 (2.94) 0 (0)
Absent 41 (100) 33 (97.06) 16 (100)